Keyword: Kite Pharma

Allogene biotech investments

5. Allogene Therapeutics

Allogene started life with a suite of ready-made candidates—along with a whopping $300 million series A round and former Kite Pharma executives Arie Belldegrun and David Chang as co-founders.